Name: New Drugs in Cancer Chemotherapy (Recent Results in Cancer Research) (en Inglés)
Price: 61660.00 CLP
Availability: InStock
Author: Carter S. K.,Sakurai Y.,Umezawa H.
ISBN: 9783642815676

portada New Drugs in Cancer Chemotherapy (Recent Results in Cancer Research) (en Inglés)

New Drugs in Cancer Chemotherapy (Recent Results in Cancer Research) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Carter S. K.,Sakurai Y.,Umezawa H.

Idioma

Inglés

N° páginas

352

Encuadernación

Tapa Blanda

ISBN13

9783642815676

N° edición

New Drugs in Cancer Chemotherapy (Recent Results in Cancer Research) (en Inglés)

Carter S. K.,Sakurai Y.,Umezawa H. (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 13 a 18 días háb.

$ 123.320$ 61.660

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 61.660

Llega entre el 05 Ago y el 12 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "New Drugs in Cancer Chemotherapy (Recent Results in Cancer Research) (en Inglés)"

The Analog Potential in Cancer Chemotherapy in the United States and Japan S. K. Carter Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304 The bilateral collaborative program in cancer research between Japan and the United States is one of the oldest programs of this type. It is sponsored in the United States by the National Cancer Institute [1], while in Japan the sponsoring organization is the Japan Society for the Promotion of Science. Annual symposia concerning treatment have been held and in recent years they have been published [2, 3]. Drug development in both Japan and the United States has evolved over the years to an increasing emphasis on second generation compounds. This has come about as a result of the initial successes of chemotherapy development. Many active structures have been uncovered and the armamentarium of the medical and pediatric oncologist has grown dramatically. The uncovering of an active structure provides an opportunity for analog synthesis and attempts at elucidating structure-activity relationships. It is hoped that the therapeutic index of active structures can be improved so as to achieve superior clinical results.